BCM
LLY icon

Becker Capital Management’s Eli Lilly LLY Stock Holding History

Becker Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.9M Buy
23,766
+990
+4% +$1M 0.64% 56
2025
Q4 		$24.5M Buy
22,776
+1,099
+5% +$1.05M 0.7% 49
2025
Q3 		$16.5M Buy
21,677
+1,353
+7% +$1.01M 0.48% 64
2025
Q2 		$15.8M Buy
20,324
+16,022
+372% +$12.5M 0.49% 64
2025
Q1 		$3.55M Sell
4,302
-52
-1% -$43.3K 0.12% 115
2024
Q4 		$3.36M Sell
4,354
-34
-0.8% -$28.2K 0.11% 116
2024
Q3 		$3.89M Buy
4,388
+235
+6% +$211K 0.13% 116
2024
Q2 		$3.76M Buy
4,153
+26
+0.6% +$20.8K 0.13% 114
2024
Q1 		$3.21M Buy
4,127
+18
+0.4% +$12.8K 0.11% 114
2023
Q4 		$2.4M Sell
4,109
-251
-6% -$147K 0.09% 121
2023
Q3 		$2.34M Sell
4,360
-276
-6% -$142K 0.09% 119
2023
Q2 		$2.17M Sell
4,636
-23
-0.5% -$9.65K 0.08% 125
2023
Q1 		$1.6M Buy
4,659
+1,210
+35% +$408K 0.06% 134
2022
Q4 		$1.26M Sell
3,449
-42
-1% -$14.9K 0.06% 115
2022
Q3 		$1.13M Sell
3,491
-87
-2% -$27.6K 0.06% 119
2022
Q2 		$1.16M Hold
3,578
– – 0.06% 121
2022
Q1 		$1.02M Buy
3,578
+999
+39% +$257K 0.04% 133
2021
Q4 		$712K Sell
2,579
-202
-7% -$51.2K 0.03% 147
2021
Q3 		$643K Sell
2,781
-333
-11% -$82.2K 0.03% 147
2021
Q2 		$715K Buy
3,114
+61
+2% +$12.3K 0.03% 140
2021
Q1 		$570K Buy
3,053
+1
+0% +$196 0.03% 147
2020
Q4 		$515K Buy
3,052
+78
+3% +$11.6K 0.03% 141
2020
Q3 		$440K Sell
2,974
-97
-3% -$15K 0.02% 137
2020
Q2 		$504K Buy
3,071
+400
+15% +$61.4K 0.03% 125
2020
Q1 		$371K Hold
2,671
– – 0.02% 137
2019
Q4 		$351K Sell
2,671
-145
-5% -$16.8K 0.01% 150
2019
Q3 		$315K Sell
2,816
-1,050
-27% -$117K 0.01% 145
2019
Q2 		$428K Buy
3,866
+50
+1% +$5.89K 0.02% 137
2019
Q1 		$495K Buy
3,816
+1,595
+72% +$194K 0.02% 137
2018
Q4 		$257K Buy
2,221
+129
+6% +$14.4K 0.01% 160
2018
Q3 		$224K Buy
+2,092
New +$209K 0.01% 180
2018
Q1 		– Sell
-2,671
Closed -$226K – 180
2017
Q4 		$226K Sell
2,671
-3,505
-57% -$298K 0.01% 155
2017
Q3 		$528K Buy
6,176
+75
+1% +$6.15K 0.02% 110
2017
Q2 		$502K Sell
6,101
-220
-3% -$17.9K 0.02% 104
2017
Q1 		$532K Sell
6,321
-1,590
-20% -$127K 0.02% 103
2016
Q4 		$582K Sell
7,911
-986
-11% -$73.4K 0.02% 100
2016
Q3 		$714K Sell
8,897
-2,035
-19% -$163K 0.03% 91
2016
Q2 		$861K Sell
10,932
-318
-3% -$23.9K 0.04% 85
2016
Q1 		$810K Hold
11,250
– – 0.03% 81
2015
Q4 		$948K Buy
11,250
+2,308
+26% +$192K 0.04% 85
2015
Q3 		$748K Hold
8,942
– – 0.03% 84
2015
Q2 		$747K Hold
8,942
– – 0.03% 92
2015
Q1 		$650K Hold
8,942
– – 0.03% 95
2014
Q4 		$617K Sell
8,942
-1,025
-10% -$69.2K 0.02% 102
2014
Q3 		$646K Hold
9,967
– – 0.03% 101
2014
Q2 		$620K Hold
9,967
– – 0.03% 100
2014
Q1 		$587K Sell
9,967
-3,050
-23% -$170K 0.02% 104
2013
Q4 		$664K Sell
13,017
-285
-2% -$14.3K 0.03% 101
2013
Q3 		$669K Sell
13,302
-281
-2% -$14.7K 0.03% 100
2013
Q2 		$667K Buy
+13,583
New +$739K 0.03% 93

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Becker Capital Management's LLY Position: Q1 2026 in Review

Becker Capital Management increased its Eli Lilly (LLY) stake by 4.3% in Q1 2026, buying an estimated $1M and bringing the position to 23,766 shares worth $21.9M. The position accounts for 0.64% of the portfolio, ranked #56.

Becker Capital Management first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $24.5M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Becker Capital Management held 23,766 shares of Eli Lilly worth $21.9M as of Q1 2026.
  • Becker Capital Management bought 990 Eli Lilly shares in Q1 2026, an estimated $1M.
  • Eli Lilly made up 0.64% of Becker Capital Management's portfolio in Q1 2026, its #56 holding.
  • Becker Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Becker Capital Management's Eli Lilly position peaked at $24.5M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Becker Capital Management's 13F filing for Q1 2026, filed 11 May 2026.